Inogen Stock Price, News & Analysis (NASDAQ:INGN)

$131.15 +1.66 (+1.28 %)
(As of 02/25/2018 04:00 PM ET)
Previous Close$131.15
Today's Range$127.63 - $132.21
52-Week Range$67.34 - $132.68
Volume69,575 shs
Average Volume109,943 shs
Market Capitalization$2.74 billion
P/E Ratio106.63
Dividend YieldN/A
Beta1.02

About Inogen (NASDAQ:INGN)

Inogen logoInogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.

Receive INGN News and Ratings via Email

Sign-up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:INGN
CUSIPN/A
Phone805-562-0500

Debt

Debt-to-Equity RatioN/A
Current Ratio6.20%
Quick Ratio5.73%

Price-To-Earnings

Trailing P/E Ratio106.63
Forward P/E Ratio110.21
P/E Growth4.27

Sales & Book Value

Annual Sales$202.83 million
Price / Sales13.49
Cash Flow$1.68 per share
Price / Cash78.00
Book Value$8.99 per share
Price / Book14.59

Profitability

Trailing EPS$1.23
Net Income$20.51 million
Net Margins11.36%
Return on Equity13.37%
Return on Assets11.16%

Miscellaneous

Employees166
Outstanding Shares20,870,000

Inogen (NASDAQ:INGN) Frequently Asked Questions

What is Inogen's stock symbol?

Inogen trades on the NASDAQ under the ticker symbol "INGN."

How were Inogen's earnings last quarter?

Inogen Inc (NASDAQ:INGN) announced its quarterly earnings results on Tuesday, November, 7th. The medical technology company reported $0.33 EPS for the quarter, beating the Zacks' consensus estimate of $0.29 by $0.04. The medical technology company earned $69 million during the quarter, compared to the consensus estimate of $63.55 million. Inogen had a net margin of 11.36% and a return on equity of 13.37%. The firm's revenue for the quarter was up 26.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.25 EPS. View Inogen's Earnings History.

Where is Inogen's stock going? Where will Inogen's stock price be in 2018?

6 Wall Street analysts have issued 1 year price objectives for Inogen's shares. Their predictions range from $75.00 to $125.00. On average, they anticipate Inogen's share price to reach $98.50 in the next year. View Analyst Ratings for Inogen.

Who are some of Inogen's key competitors?

Who are Inogen's key executives?

Inogen's management team includes the folowing people:

  • Heath Lukatch Ph.D., Independent Chairman of the Board
  • Scott Wilkinson, President, Chief Executive Officer, Director
  • Alison Bauerlein, Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate Treasurer
  • Byron Myers, Executive Vice President of Sales and Marketing
  • Matthew Scribner, Executive Vice President - Operations
  • Brenton Taylor, Executive Vice President - Engineering
  • Benjamin M. Anderson-Ray, Independent Director
  • Scott A. Beardsley, Independent Director
  • R. Scott Greer, Independent Director
  • Raymond O. Huggenberger, Independent Director

Who owns Inogen stock?

Inogen's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.05%), Brown Capital Management LLC (10.83%), TimesSquare Capital Management LLC (1.67%), Rockefeller Financial Services Inc. (1.44%), Bank of New York Mellon Corp (1.36%) and Wells Fargo & Company MN (1.32%). Company insiders that own Inogen stock include Alison Bauerlein, Brenton Taylor, Byron Myers, Heath Lukatch, Matt Scribner, Ray Benjamin M Anderson, Raymond Huggenberger and Scott Wilkinson. View Institutional Ownership Trends for Inogen.

Who sold Inogen stock? Who is selling Inogen stock?

Inogen's stock was sold by a variety of institutional investors in the last quarter, including Cortina Asset Management LLC, TimesSquare Capital Management LLC, Goldman Sachs Group Inc., Deutsche Bank AG, Driehaus Capital Management LLC, Bank of Montreal Can, Allianz Asset Management GmbH and Wells Fargo & Company MN. Company insiders that have sold Inogen company stock in the last year include Alison Bauerlein, Brenton Taylor, Byron Myers, Heath Lukatch, Matt Scribner, Ray Benjamin M Anderson, Raymond Huggenberger and Scott Wilkinson. View Insider Buying and Selling for Inogen.

Who bought Inogen stock? Who is buying Inogen stock?

Inogen's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Rock Springs Capital Management LP, Fuller & Thaler Asset Management Inc., WINTON GROUP Ltd, Renaissance Technologies LLC, Brown Capital Management LLC, Amundi Pioneer Asset Management Inc. and Arizona State Retirement System. View Insider Buying and Selling for Inogen.

How do I buy Inogen stock?

Shares of Inogen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Inogen's stock price today?

One share of Inogen stock can currently be purchased for approximately $131.15.

How big of a company is Inogen?

Inogen has a market capitalization of $2.74 billion and generates $202.83 million in revenue each year. The medical technology company earns $20.51 million in net income (profit) each year or $1.23 on an earnings per share basis. Inogen employs 166 workers across the globe.

How can I contact Inogen?

Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The medical technology company can be reached via phone at 805-562-0500 or via email at [email protected]


MarketBeat Community Rating for Inogen (INGN)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  214 (Vote Outperform)
Underperform Votes:  107 (Vote Underperform)
Total Votes:  321
MarketBeat's community ratings are surveys of what our community members think about Inogen and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Inogen (NASDAQ:INGN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.672.672.75
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $98.50$98.50$98.50$91.00
Price Target Upside: 20.86% downside16.61% downside16.61% downside3.33% downside

Inogen (NASDAQ:INGN) Consensus Price Target History

Price Target History for Inogen (NASDAQ:INGN)

Inogen (NASDAQ:INGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/20/2018Piper Jaffray CompaniesUpgradeNeutral -> OverweightMediumView Rating Details
11/8/2017Leerink SwannReiterated RatingOutperform$115.00 -> $120.00N/AView Rating Details
11/8/2017Needham & Company LLCBoost Price TargetStrong-Buy$108.00 -> $125.00N/AView Rating Details
6/26/2017JPMorgan Chase & Co.Boost Price TargetOverweight$102.00LowView Rating Details
5/10/2017Stifel NicolausBoost Price TargetHold -> Hold$65.00 -> $75.00HighView Rating Details
4/18/2017SidotiInitiated CoverageNeutral -> Neutral$79.00MediumView Rating Details
(Data available from 2/25/2016 forward)

Earnings

Inogen (NASDAQ:INGN) Earnings History and Estimates Chart

Earnings by Quarter for Inogen (NASDAQ:INGN)

Inogen (NASDAQ INGN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2017Q3 2017$0.29$0.33$63.55 million$69.00 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.28$0.38$59.99 million$64.10 millionViewListenView Earnings Details
5/9/2017Q1 2017$0.12$0.27$49.06 million$52.50 millionViewListenView Earnings Details
2/28/2017Q416$0.10$0.25$46.19 million$50.85 millionViewListenView Earnings Details
11/3/2016Q316$0.13$0.16$47.89 million$54.42 millionViewN/AView Earnings Details
8/4/2016Q216$0.20$0.25$52.44 million$54.57 millionViewN/AView Earnings Details
5/9/2016Q116$0.12$0.11$41.75 million$43.00 millionViewN/AView Earnings Details
3/14/2016Q415$0.07$0.19$29.10 million$40.40 millionViewN/AView Earnings Details
11/10/2015Q315$0.13$0.13$36.99 million$40.80 millionViewListenView Earnings Details
8/11/2015Q215$0.15$0.17$36.88 million$44.00 millionViewListenView Earnings Details
5/12/2015Q1$0.07$0.08$29.98 million$33.70 millionViewListenView Earnings Details
4/27/2015Q115$0.03$0.06$19.80 million$29.10 millionViewN/AView Earnings Details
11/11/2014Q3 2014$0.06$0.11$28.00 million$29.40 millionViewN/AView Earnings Details
8/12/2014Q214$0.07$0.11$23.93 million$30.40 millionViewN/AView Earnings Details
5/13/2014Q114$0.04$0.05$20.70 million$23.60 millionViewN/AView Earnings Details
3/27/2014Q4 13$0.02$0.89$18.71 million$19.76 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Inogen (NASDAQ:INGN) Earnings Estimates

2018 EPS Consensus Estimate: $1.45
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.22$0.31$0.27
Q2 20182$0.44$0.45$0.45
Q3 20182$0.42$0.44$0.43
Q4 20182$0.30$0.31$0.31
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Inogen (NASDAQ:INGN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Inogen (NASDAQ INGN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.31%
Insider Trades by Quarter for Inogen (NASDAQ:INGN)
Institutional Ownership by Quarter for Inogen (NASDAQ:INGN)

Inogen (NASDAQ INGN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/21/2018Brenton TaylorEVPSell5,000$130.76$653,800.0038,982View SEC Filing  
2/20/2018Alison BauerleinCFOSell3,192$125.41$400,308.728,808View SEC Filing  
2/16/2018Alison BauerleinCFOSell8,808$125.03$1,101,264.248,808View SEC Filing  
2/16/2018Brenton TaylorEVPSell5,000$125.06$625,300.0038,982View SEC Filing  
2/14/2018Alison BauerleinCFOSell9,737$120.05$1,168,926.859,737View SEC Filing  
2/14/2018Brenton TaylorEVPSell15,000$117.47$1,762,050.0038,982View SEC Filing  
2/12/2018Alison BauerleinEVPSell27,630$116.46$3,217,789.8011,718View SEC Filing  
2/9/2018Alison BauerleinCFOSell11,718$115.87$1,357,764.6611,718View SEC Filing  
1/16/2018Matt ScribnerEVPSell2,500$116.17$290,425.007,297View SEC Filing  
1/16/2018Raymond HuggenbergerDirectorSell13,000$116.19$1,510,470.0010,208View SEC Filing  
1/16/2018Scott WilkinsonInsiderSell30,651$115.75$3,547,853.2538,107View SEC Filing  
1/2/2018Ray Benjamin M AndersonDirectorSell1,000$119.06$119,060.001,000View SEC Filing  
12/15/2017Raymond HuggenbergerDirectorSell14,000$119.92$1,678,880.007,808View SEC Filing  
12/14/2017Matt ScribnerEVPSell2,500$120.34$300,850.007,297View SEC Filing  
12/11/2017Byron MyersEVPSell10,000$116.81$1,168,100.0048,600View SEC Filing  
12/1/2017Heath LukatchDirectorSell2,500$126.40$316,000.00View SEC Filing  
11/17/2017Byron MyersEVPSell35,000$116.77$4,086,950.0048,600View SEC Filing  
11/13/2017Matt ScribnerEVPSell2,500$112.35$280,875.00View SEC Filing  
10/16/2017Raymond HuggenbergerDirectorSell14,000$94.07$1,316,980.007,808View SEC Filing  
10/12/2017Matt ScribnerEVPSell2,500$93.88$234,700.00View SEC Filing  
10/10/2017Alison BauerleinEVPSell15,000$94.93$1,423,950.00View SEC Filing  
9/15/2017Raymond HuggenbergerDirectorSell14,000$102.30$1,432,200.007,808View SEC Filing  
9/11/2017Matt ScribnerEVPSell2,500$103.23$258,075.006,964View SEC Filing  
9/6/2017Heath LukatchDirectorSell2,500$97.44$243,600.002,500View SEC Filing  
8/18/2017Matt ScribnerEVPSell2,500$92.45$231,125.006,964View SEC Filing  
8/15/2017Raymond HuggenbergerDirectorSell14,000$91.67$1,283,380.007,808View SEC Filing  
8/10/2017Alison BauerleinEVPSell6,667$92.64$617,630.8815,000View SEC Filing  
7/18/2017Matt ScribnerEVPSell2,500$94.21$235,525.004,833View SEC Filing  
7/14/2017Raymond HuggenbergerDirectorSell14,000$92.96$1,301,440.007,808View SEC Filing  
6/16/2017Matt ScribnerEVPSell2,500$91.54$228,850.004,833View SEC Filing  
6/15/2017Raymond HuggenbergerDirectorSell15,300$90.88$1,390,464.007,808View SEC Filing  
6/2/2017Byron MyersEVPSell10,000$90.00$900,000.0045,185View SEC Filing  
6/1/2017Scott WilkinsonInsiderSell23,437$88.06$2,063,862.2254,088View SEC Filing  
5/30/2017Heath LukatchDirectorSell9,000$88.52$796,680.007,246View SEC Filing  
5/18/2017Ray Benjamin M AndersonDirectorSell4,445$81.05$360,267.254,445View SEC Filing  
5/10/2017Alison BauerleinEVPSell6,666$83.24$554,877.8425,758View SEC Filing  
4/24/2017Byron MyersEVPSell10,000$80.00$800,000.0045,185View SEC Filing  
4/17/2017Matt ScribnerEVPSell2,500$75.28$188,200.004,064View SEC Filing  
3/15/2017Matt ScribnerEVPSell2,500$73.85$184,625.004,833View SEC Filing  
2/28/2017Brenton TaylorEVPSell3,750$70.07$262,762.5031,851View SEC Filing  
1/17/2017Matt ScribnerEVPSell2,500$63.91$159,775.004,833View SEC Filing  
1/17/2017Raymond HuggenbergerCEOSell5,680$63.96$363,292.8012,488View SEC Filing  
1/10/2017Brenton TaylorEVPSell5,105$65.31$333,407.5531,851View SEC Filing  
1/3/2017Brenton TaylorEVPSell31,823$65.69$2,090,452.8763,674View SEC Filing  
12/15/2016Raymond HuggenbergerCEOSell8,000$65.59$524,720.0014,808View SEC Filing  
12/14/2016Matt ScribnerEVPSell2,500$65.13$162,825.004,833View SEC Filing  
12/1/2016Scott WilkinsonInsiderSell26,706$61.64$1,646,157.8466,050View SEC Filing  
11/14/2016Matt ScribnerEVPSell2,500$63.80$159,500.004,833View SEC Filing  
10/17/2016Raymond HuggenbergerCEOSell7,089$56.24$398,685.368,342View SEC Filing  
10/12/2016Matt ScribnerEVPSell4,551$59.45$270,556.956,884View SEC Filing  
9/19/2016Matt ScribnerEVPSell4,551$60.18$273,879.186,884View SEC Filing  
9/16/2016Byron MyersVPSell6,200$60.04$372,248.0041,385View SEC Filing  
9/9/2016Byron MyersVPSell3,800$60.07$228,266.0035,585View SEC Filing  
8/18/2016Matt ScribnerEVPSell2,320$56.39$130,824.804,653View SEC Filing  
8/15/2016Raymond HuggenbergerCEOSell20,747$57.48$1,192,537.5627,555View SEC Filing  
8/9/2016Byron MyersVPSell13,000$55.00$715,000.0035,185View SEC Filing  
7/18/2016Matt ScribnerEVPSell4,102$50.46$206,986.926,435View SEC Filing  
7/18/2016Raymond HuggenbergerCEOSell20,747$50.41$1,045,856.2727,555View SEC Filing  
6/16/2016Matt ScribnerEVPSell4,102$47.66$195,501.322,738View SEC Filing  
6/16/2016Raymond HuggenbergerCEOSell20,747$47.86$992,951.4227,555View SEC Filing  
5/16/2016Matt ScribnerEVPSell4,102$43.82$179,749.646,435View SEC Filing  
5/16/2016Raymond HuggenbergerCEOSell20,746$44.18$916,558.2827,554View SEC Filing  
4/15/2016Matt ScribnerEVPSell4,102$48.62$199,439.246,435View SEC Filing  
4/15/2016Raymond HuggenbergerCEOSell29,635$48.59$1,439,964.6525,210View SEC Filing  
4/13/2016Brenton TaylorEVPSell6,500$48.00$312,000.0031,851View SEC Filing  
4/6/2016Alison BauerleinCFOSell9,278$46.18$428,458.0438,332View SEC Filing  
3/31/2016Alison BauerleinCFOSell4,360$44.33$193,278.8048,332View SEC Filing  
2/16/2016Matt ScribnerEVPSell4,102$30.26$124,126.522,333View SEC Filing  
1/14/2016Matt ScribnerEVPSell4,102$34.73$142,462.462,333View SEC Filing  
12/14/2015Matt ScribnerEVPSell4,102$40.40$165,720.802,333View SEC Filing  
11/12/2015Matt ScribnerEVPSell4,102$44.52$182,621.042,333View SEC Filing  
10/26/2015Brenton TaylorEVPSell5,000$41.38$206,900.0043,351View SEC Filing  
10/21/2015Raymond HuggenbergerCEOSell57,418$43.06$2,472,419.086,808View SEC Filing  
10/12/2015Matt ScribnerEVPSell4,102$44.06$180,734.122,333View SEC Filing  
10/1/2015Alison BauerleinCFOSell10,185$47.94$488,268.9043,890View SEC Filing  
9/25/2015Brenton TaylorEVPSell3,333$53.48$178,248.8443,351View SEC Filing  
9/16/2015Byron MyersVPSell1,700$55.00$93,500.0036,332View SEC Filing  
9/15/2015Raymond HuggenbergerCEOSell57,416$53.58$3,076,349.286,808View SEC Filing  
9/14/2015Byron MyersVPSell7,950$55.23$439,078.5036,332View SEC Filing  
9/10/2015Matt ScribnerEVPSell4,102$53.30$218,636.604,666View SEC Filing  
9/1/2015Alison BauerleinCFOSell6,500$48.21$313,365.0049,075View SEC Filing  
8/26/2015Scott WilkinsonEVPSell6,666$45.42$302,769.72View SEC Filing  
8/25/2015Brenton TaylorEVPSell3,333$46.84$156,117.7246,684View SEC Filing  
8/25/2015Ray Benjamin M. AndersonDirectorSell5,658$46.36$262,304.884,896View SEC Filing  
5/28/2015Timothy PetersenDirectorSell337,081$37.44$12,620,312.64View SEC Filing  
5/26/2015Timothy PetersenDirectorSell54,258$37.05$2,010,258.90View SEC Filing  
5/22/2015Timothy PetersenDirectorSell86,889$37.09$3,222,713.01View SEC Filing  
5/21/2015Timothy PetersenDirectorSell134,300$37.81$5,077,883.00View SEC Filing  
5/19/2015Timothy PetersenDirectorSell115,700$37.25$4,309,825.00View SEC Filing  
5/18/2015Timothy PetersenDirectorSell58,987$37.35$2,203,164.45View SEC Filing  
3/5/2015Matt ScribnerEVPSell4,102$33.69$138,196.38View SEC Filing  
2/25/2015Brenton TaylorEVPSell15,687$33.87$531,318.69View SEC Filing  
2/23/2015Alison BauerleinCFOSell15,687$33.10$519,239.70View SEC Filing  
2/19/2015Raymond HuggenbergerCEOSell25,722$33.95$873,261.90View SEC Filing  
2/13/2015Scott WilkinsonEVPSell18,333$32.87$602,605.71View SEC Filing  
2/5/2015Matt ScribnerEVPSell4,102$30.66$125,767.32View SEC Filing  
2/3/2015Timothy PetersenDirectorSell17,000$30.25$514,250.00View SEC Filing  
2/2/2015Timothy PetersenDirectorSell99,000$30.88$3,057,120.00View SEC Filing  
1/29/2015Timothy PetersenDirectorSell601,000$31.95$19,201,950.00View SEC Filing  
1/26/2015Brenton TaylorEVPSell15,687$31.53$494,611.11View SEC Filing  
1/23/2015Alison BauerleinCFOSell15,687$31.53$494,611.11View SEC Filing  
1/20/2015Raymond HuggenbergerCEOSell25,722$31.63$813,586.86View SEC Filing  
1/5/2015Matt ScribnerEVPSell4,102$31.14$127,736.28View SEC Filing  
1/5/2015Versant Ventures Ii LlcMajor ShareholderSell7,946$30.98$246,167.08View SEC Filing  
12/30/2014Scott WilkinsonEVPSell962$30.50$29,341.00View SEC Filing  
12/29/2014Scott WilkinsonEVPSell15,735$30.52$480,232.20View SEC Filing  
12/24/2014Byron MyersVPSell7,514$30.07$225,945.98View SEC Filing  
12/23/2014Alison BauerleinCFOSell15,687$29.85$468,256.95View SEC Filing  
12/23/2014Byron MyersVPSell3,018$30.04$90,660.72View SEC Filing  
12/23/2014Versant Ventures Ii LlcMajor ShareholderSell9,785$29.74$291,005.90View SEC Filing  
12/22/2014Byron MyersVPSell11,801$30.06$354,738.06View SEC Filing  
12/22/2014Scott WilkinsonEVPSell1,033$30.31$31,310.23View SEC Filing  
12/19/2014Raymond HuggenbergerCEOSell25,722$28.98$745,423.56View SEC Filing  
12/11/2014Scott WilkinsonEVPSell14,700$25.25$371,175.00View SEC Filing  
12/3/2014Matt ScribnerEVPSell4,102$24.09$98,817.18View SEC Filing  
11/25/2014Brenton TaylorEVPSell15,687$24.71$387,625.77View SEC Filing  
11/21/2014Alison BauerleinCFOSell15,687$24.49$384,174.63View SEC Filing  
11/19/2014Raymond HuggenbergerCEOSell25,722$24.25$623,758.50View SEC Filing  
11/19/2014Versant Ventures Ii LlcMajor ShareholderSell28,225$24.77$699,133.25View SEC Filing  
11/18/2014Scott WilkinsonEVPSell2,233$25.21$56,293.93View SEC Filing  
11/18/2014Versant Ventures Ii LlcMajor ShareholderSell11,848$24.83$294,185.84View SEC Filing  
11/17/2014Versant Ventures Ii LlcMajor ShareholderSell5,343$24.89$132,987.27View SEC Filing  
11/14/2014Heather D RiderDirectorBuy3,000$25.00$75,000.00View SEC Filing  
11/14/2014Scott WilkinsonEVPSell1,100$25.15$27,665.00View SEC Filing  
11/14/2014Versant Ventures Ii LlcMajor ShareholderSell9,433$25.13$237,051.29View SEC Filing  
11/10/2014Versant Ventures Ii LlcMajor ShareholderSell2,992$24.42$73,064.64View SEC Filing  
11/7/2014Versant Ventures Ii LlcMajor ShareholderSell7,388$24.30$179,528.40View SEC Filing  
11/4/2014A/S NovoMajor ShareholderSell2,000,000$21.50$43,000,000.00View SEC Filing  
11/4/2014Raymond HuggenbergerCEOSell165,891$20.21$3,352,657.11View SEC Filing  
11/4/2014Timothy PetersenDirectorSell250,000$21.50$5,375,000.00View SEC Filing  
11/3/2014Matt ScribnerEVPSell4,102$24.08$98,776.16View SEC Filing  
10/29/2014Scott WilkinsonEVPSell18,333$22.41$410,842.53View SEC Filing  
10/27/2014Brenton TaylorEVPSell15,687$21.67$339,937.29View SEC Filing  
10/24/2014Versant Ventures Ii LlcMajor ShareholderSell4,647$20.76$96,471.72View SEC Filing  
10/23/2014Alison BauerleinCFOSell15,687$20.50$321,583.50View SEC Filing  
10/9/2014Versant Ventures Ii LlcMajor ShareholderSell1,900$20.83$39,577.00View SEC Filing  
10/8/2014Versant Ventures Ii LlcMajor ShareholderSell6,907$21.03$145,254.21View SEC Filing  
10/7/2014Timothy PetersenDirectorSell31,600$21.55$680,980.00View SEC Filing  
10/6/2014Timothy PetersenDirectorSell17,475$21.56$376,761.00View SEC Filing  
10/3/2014Timothy PetersenDirectorSell31,658$21.52$681,280.16View SEC Filing  
10/3/2014Ventures Lp Arboretum IIMajor ShareholderSell98,400$20.97$2,063,448.00View SEC Filing  
10/2/2014Timothy PetersenDirectorSell24,597$20.91$514,323.27View SEC Filing  
10/1/2014Matt ScribnerEVPSell8,204$20.25$166,131.00View SEC Filing  
10/1/2014Timothy PetersenDirectorSell42,145$20.61$868,608.45View SEC Filing  
9/30/2014Timothy PetersenDirectorSell84,500$20.23$1,709,435.00View SEC Filing  
9/24/2014Ventures Lp Arboretum IIMajor ShareholderSell83,500$20.34$1,698,390.00View SEC Filing  
9/23/2014Alison BauerleinCFOSell15,687$20.01$313,896.87View SEC Filing  
9/22/2014Raymond HuggenbergerCEOSell25,722$20.25$520,870.50View SEC Filing  
9/22/2014Timothy PetersenDirectorSell46,865$21.05$986,508.25View SEC Filing  
9/17/2014Timothy PetersenDirectorSell39,135$21.72$850,012.20View SEC Filing  
9/17/2014Ventures Lp Arboretum IIMajor ShareholderSell55,135$21.61$1,191,467.35View SEC Filing  
9/16/2014Timothy PetersenDirectorSell6,500$21.16$137,540.00View SEC Filing  
9/15/2014Byron MyersVPSell22,333$21.33$476,362.89View SEC Filing  
9/15/2014Scott WilkinsonEVPSell18,333$21.42$392,692.86View SEC Filing  
9/15/2014Timothy PetersenDirectorSell9,500$21.45$203,775.00View SEC Filing  
9/9/2014Versant Ventures Ii LlcMajor ShareholderSell7,388$23.25$171,771.00View SEC Filing  
3/7/2014Charles E LarsenDirectorSell26,201$14.88$389,870.88View SEC Filing  
2/20/2014A/S NovoInsiderSell617,000$14.88$9,180,960.00View SEC Filing  
2/20/2014Loren L McfarlandDirectorBuy3,125$16.00$50,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Inogen (NASDAQ INGN) News Headlines

Source:
DateHeadline
Inogen Inc (INGN) Position Reduced by Employees Retirement System of TexasInogen Inc (INGN) Position Reduced by Employees Retirement System of Texas
www.americanbankingnews.com - February 25 at 5:20 AM
Inogen Inc (INGN) Holdings Raised by Aperio Group LLCInogen Inc (INGN) Holdings Raised by Aperio Group LLC
www.americanbankingnews.com - February 25 at 4:14 AM
 Brokerages Anticipate Inogen Inc (INGN) to Announce $0.21 EPS Brokerages Anticipate Inogen Inc (INGN) to Announce $0.21 EPS
www.americanbankingnews.com - February 23 at 9:14 PM
Inogen Inc (INGN) EVP Brenton Taylor Sells 5,000 SharesInogen Inc (INGN) EVP Brenton Taylor Sells 5,000 Shares
www.americanbankingnews.com - February 23 at 6:32 PM
Commit To Purchase Inogen At $100, Earn 6.1% Annualized Using OptionsCommit To Purchase Inogen At $100, Earn 6.1% Annualized Using Options
www.nasdaq.com - February 23 at 5:13 PM
Inogen Inc (INGN) Given Consensus Rating of "Buy" by BrokeragesInogen Inc (INGN) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - February 21 at 11:19 AM
Is a Beat in Store for Inogen (INGN) This Earnings Season?Is a Beat in Store for Inogen (INGN) This Earnings Season?
finance.yahoo.com - February 21 at 9:07 AM
Inogen (INGN) Raised to Overweight at Piper Jaffray CompaniesInogen (INGN) Raised to Overweight at Piper Jaffray Companies
www.americanbankingnews.com - February 20 at 11:12 PM
Alison Bauerlein Sells 3,192 Shares of Inogen Inc (INGN) StockAlison Bauerlein Sells 3,192 Shares of Inogen Inc (INGN) Stock
www.americanbankingnews.com - February 20 at 9:30 PM
Inogen Inc (INGN) CFO Sells $1,101,264.24 in StockInogen Inc (INGN) CFO Sells $1,101,264.24 in Stock
www.americanbankingnews.com - February 20 at 9:12 PM
Insider Selling: Inogen Inc (INGN) EVP Sells 5,000 Shares of StockInsider Selling: Inogen Inc (INGN) EVP Sells 5,000 Shares of Stock
www.americanbankingnews.com - February 20 at 9:12 PM
Inogen (INGN) Upgraded to "Buy" at Zacks Investment ResearchInogen (INGN) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - February 19 at 3:38 PM
Insider Selling: Inogen Inc (INGN) EVP Sells 15,000 Shares of StockInsider Selling: Inogen Inc (INGN) EVP Sells 15,000 Shares of Stock
www.americanbankingnews.com - February 16 at 12:26 AM
Insider Selling: Inogen Inc (INGN) CFO Sells 9,737 Shares of StockInsider Selling: Inogen Inc (INGN) CFO Sells 9,737 Shares of Stock
www.americanbankingnews.com - February 16 at 12:26 AM
Inogen (INGN) Gains on Diverse Product Line, Competition RifeInogen (INGN) Gains on Diverse Product Line, Competition Rife
finance.yahoo.com - February 15 at 4:49 PM
Inogen (INGN) Downgraded by Zacks Investment Research to HoldInogen (INGN) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - February 14 at 12:24 PM
Insider Selling: Inogen Inc (INGN) EVP Sells 27,630 Shares of StockInsider Selling: Inogen Inc (INGN) EVP Sells 27,630 Shares of Stock
www.americanbankingnews.com - February 13 at 9:10 PM
Inogen Inc (INGN) CFO Alison Bauerlein Sells 11,718 SharesInogen Inc (INGN) CFO Alison Bauerlein Sells 11,718 Shares
www.americanbankingnews.com - February 13 at 9:10 PM
Inogen (INGN) Rating Increased to Buy at Zacks Investment ResearchInogen (INGN) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - February 13 at 5:24 PM
Inogen (INGN) Stock Rating Upgraded by BidaskClubInogen (INGN) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - February 10 at 1:32 PM
$62.01 Million in Sales Expected for Inogen Inc (INGN) This Quarter$62.01 Million in Sales Expected for Inogen Inc (INGN) This Quarter
www.americanbankingnews.com - February 8 at 2:10 AM
Zacks Investment Research Lowers Inogen (INGN) to HoldZacks Investment Research Lowers Inogen (INGN) to Hold
www.americanbankingnews.com - February 7 at 1:18 PM
 Brokerages Anticipate Inogen Inc (INGN) to Post $0.21 EPS Brokerages Anticipate Inogen Inc (INGN) to Post $0.21 EPS
www.americanbankingnews.com - February 6 at 9:14 PM
Inogen (INGN) Upgraded to Hold at BidaskClubInogen (INGN) Upgraded to Hold at BidaskClub
www.americanbankingnews.com - January 29 at 11:46 PM
Inogen Inc (INGN) Receives Average Recommendation of "Buy" from BrokeragesInogen Inc (INGN) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - January 27 at 10:32 AM
Inogen Announces Participation in Upcoming Leerink Partners 7th Annual Global Healthcare ConferenceInogen Announces Participation in Upcoming Leerink Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - January 24 at 4:28 PM
Inogen to Announce Fourth Quarter and Full Year 2017 Financial Results on Tuesday, February 27, 2018Inogen to Announce Fourth Quarter and Full Year 2017 Financial Results on Tuesday, February 27, 2018
finance.yahoo.com - January 24 at 4:28 PM
Inogen Inc (INGN) Expected to Post Quarterly Sales of $61.99 MillionInogen Inc (INGN) Expected to Post Quarterly Sales of $61.99 Million
www.americanbankingnews.com - January 22 at 3:52 AM
 Brokerages Expect Inogen Inc (INGN) to Post $0.21 Earnings Per Share Brokerages Expect Inogen Inc (INGN) to Post $0.21 Earnings Per Share
www.americanbankingnews.com - January 20 at 11:26 PM
Insider Selling: Inogen Inc (INGN) EVP Sells 2,500 Shares of StockInsider Selling: Inogen Inc (INGN) EVP Sells 2,500 Shares of Stock
www.americanbankingnews.com - January 18 at 7:34 PM
Inogen Inc (INGN) Director Raymond Huggenberger Sells 13,000 SharesInogen Inc (INGN) Director Raymond Huggenberger Sells 13,000 Shares
www.americanbankingnews.com - January 18 at 7:00 PM
Scott Wilkinson Sells 30,651 Shares of Inogen Inc (INGN) StockScott Wilkinson Sells 30,651 Shares of Inogen Inc (INGN) Stock
www.americanbankingnews.com - January 18 at 6:34 PM
Critical Survey: Inogen (INGN) versus VWR (VWR)Critical Survey: Inogen (INGN) versus VWR (VWR)
www.americanbankingnews.com - January 13 at 3:06 PM
Inogen (INGN) Lifted to Buy at Zacks Investment ResearchInogen (INGN) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - January 9 at 3:56 PM
Inogen (INGN) vs. Neurometrix (NURO) Financial ComparisonInogen (INGN) vs. Neurometrix (NURO) Financial Comparison
www.americanbankingnews.com - January 6 at 9:12 PM
BidaskClub Downgrades Inogen (INGN) to SellBidaskClub Downgrades Inogen (INGN) to Sell
www.americanbankingnews.com - January 6 at 6:40 PM
 Analysts Expect Inogen Inc (INGN) Will Announce Quarterly Sales of $61.99 Million Analysts Expect Inogen Inc (INGN) Will Announce Quarterly Sales of $61.99 Million
www.americanbankingnews.com - January 6 at 6:32 AM
Inogen Inc (INGN) Director Ray Benjamin M. Anderson Sells 1,000 SharesInogen Inc (INGN) Director Ray Benjamin M. Anderson Sells 1,000 Shares
www.americanbankingnews.com - January 3 at 9:54 PM
Inogen Inc (INGN) Receives Consensus Recommendation of "Buy" from AnalystsInogen Inc (INGN) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - January 2 at 8:28 AM
ETFs with exposure to Inogen, Inc. : December 28, 2017ETFs with exposure to Inogen, Inc. : December 28, 2017
finance.yahoo.com - December 28 at 3:07 PM
Inogen, Inc. :INGN-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017Inogen, Inc. :INGN-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017
finance.yahoo.com - December 27 at 1:27 PM
Inogen (INGN) Rating Lowered to Hold at BidaskClubInogen (INGN) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - December 25 at 4:27 PM
$61.99 Million in Sales Expected for Inogen Inc (INGN) This Quarter$61.99 Million in Sales Expected for Inogen Inc (INGN) This Quarter
www.americanbankingnews.com - December 20 at 6:32 AM
Inogen, Inc (INGN) Director Sells $1,678,880.00 in StockInogen, Inc (INGN) Director Sells $1,678,880.00 in Stock
www.americanbankingnews.com - December 19 at 8:50 PM
Inogen, Inc (INGN) EVP Matt Scribner Sells 2,500 SharesInogen, Inc (INGN) EVP Matt Scribner Sells 2,500 Shares
www.americanbankingnews.com - December 15 at 9:22 PM
Byron Myers Sells 10,000 Shares of Inogen, Inc (INGN) StockByron Myers Sells 10,000 Shares of Inogen, Inc (INGN) Stock
www.americanbankingnews.com - December 12 at 8:42 PM
Reviewing Palomar Medical Technologies (PMTI) & Inogen (INGN)Reviewing Palomar Medical Technologies (PMTI) & Inogen (INGN)
www.americanbankingnews.com - December 12 at 3:30 PM
Inogen, Inc (INGN) Receives Average Recommendation of "Buy" from AnalystsInogen, Inc (INGN) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - December 8 at 8:22 AM
Strange: Bullish INGN Analysts Actually See -9.56% Downside - NasdaqStrange: Bullish INGN Analysts Actually See -9.56% Downside - Nasdaq
www.nasdaq.com - December 7 at 10:45 AM
Inogen, Inc (INGN) Director Heath Lukatch Sells 2,500 SharesInogen, Inc (INGN) Director Heath Lukatch Sells 2,500 Shares
www.americanbankingnews.com - December 5 at 9:00 PM

SEC Filings

Inogen (NASDAQ:INGN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Inogen (NASDAQ:INGN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Inogen (NASDAQ INGN) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.